These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29107541)

  • 1. Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units.
    Choi PJ; Sutherland HS; Tong AST; Blaser A; Franzblau SG; Cooper CB; Lotlikar MU; Upton AM; Guillemont J; Motte M; Queguiner L; Andries K; Van den Broeck W; Denny WA; Palmer BD
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5190-5196. PubMed ID: 29107541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline.
    Blaser A; Sutherland HS; Tong AST; Choi PJ; Conole D; Franzblau SG; Cooper CB; Upton AM; Lotlikar M; Denny WA; Palmer BD
    Bioorg Med Chem; 2019 Apr; 27(7):1283-1291. PubMed ID: 30792104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel.
    Sutherland HS; Tong AST; Choi PJ; Blaser A; Conole D; Franzblau SG; Lotlikar MU; Cooper CB; Upton AM; Denny WA; Palmer BD
    Bioorg Med Chem; 2019 Apr; 27(7):1292-1307. PubMed ID: 30803745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles.
    Sutherland HS; Tong AST; Choi PJ; Conole D; Blaser A; Franzblau SG; Cooper CB; Upton AM; Lotlikar MU; Denny WA; Palmer BD
    Bioorg Med Chem; 2018 May; 26(8):1797-1809. PubMed ID: 29482950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in the C-unit of bedaquiline provides analogues with improved biology and pharmacology.
    Sutherland HS; Tong AST; Choi PJ; Blaser A; Franzblau SG; Cooper CB; Upton AM; Lotlikar M; Denny WA; Palmer BD
    Bioorg Med Chem; 2020 Jan; 28(1):115213. PubMed ID: 31810890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis and Biological Evaluation of Anti-tuberculosis Agents based on Bedaquiline Structure.
    Wu C; Luo J; Wu M; Meng F; Cai Z; Chen Y; Sun T
    Med Chem; 2020; 16(5):703-714. PubMed ID: 31203803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Anti-tubercular Analogues of Bedaquiline with Modified A-, B- and C-Ring Subunits.
    Barbaro L; Nagalingam G; Triccas JA; Tan L; West NP; Priebbenow DL; Baell JB
    ChemMedChem; 2023 Jan; 18(1):e202200533. PubMed ID: 36259365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
    Worley MV; Estrada SJ
    Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Simplification of Bedaquiline: the Discovery of 3-(4-(N,N-Dimethylaminomethyl)phenyl)quinoline-Derived Antitubercular Lead Compounds.
    He C; Preiss L; Wang B; Fu L; Wen H; Zhang X; Cui H; Meier T; Yin D
    ChemMedChem; 2017 Jan; 12(2):106-119. PubMed ID: 27792278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
    Chahine EB; Karaoui LR; Mansour H
    Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection.
    Kaushik A; Ammerman NC; Tyagi S; Saini V; Vervoort I; Lachau-Durand S; Nuermberger E; Andries K
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedaquiline: a new hope to treat multi-drug resistant tuberculosis.
    Patel RV; Riyaz SD; Park SW
    Curr Top Med Chem; 2014; 14(16):1866-74. PubMed ID: 25262806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic Studies to Help Elucidate the Metabolism of the Preclinical Candidate TBAJ-876-A Less Toxic and More Potent Analogue of Bedaquiline.
    Choi PJ; Conole D; Sutherland HS; Blaser A; Tong AST; Cooper CB; Upton AM; Palmer BD; Denny WA
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32245020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis.
    Sutherland HS; Lu GL; Tong AST; Conole D; Franzblau SG; Upton AM; Lotlikar MU; Cooper CB; Palmer BD; Choi PJ; Denny WA
    Eur J Med Chem; 2022 Feb; 229():114059. PubMed ID: 34963068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis.
    Xu J; Tasneen R; Peloquin CA; Almeida DV; Li SY; Barnes-Boyle K; Lu Y; Nuermberger E
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Perspective of ATP Synthase Inhibitors in the Management of the Tuberculosis.
    Divita KM; Khatik GL
    Curr Top Med Chem; 2021; 21(18):1623-1643. PubMed ID: 34517802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of MIC distribution and epidemiological cutoff values for bedaquiline and delamanid in Mycobacterium tuberculosis using the MGIT 960 system equipped with TB eXiST.
    Keller PM; Hömke R; Ritter C; Valsesia G; Bloemberg GV; Böttger EC
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4352-5. PubMed ID: 25941226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro culture conditions affecting minimal inhibitory concentration of bedaquiline against M. tuberculosis.
    Lounis N; Vranckx L; Gevers T; Kaniga K; Andries K
    Med Mal Infect; 2016 Jun; 46(4):220-5. PubMed ID: 27210281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMC207 becomes bedaquiline, a new anti-TB drug.
    Palomino JC; Martin A
    Future Microbiol; 2013 Sep; 8(9):1071-80. PubMed ID: 24020736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.
    Hu Y; Pertinez H; Liu Y; Davies G; Coates A
    J Antimicrob Chemother; 2019 Jun; 74(6):1627-1633. PubMed ID: 30789209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.